Literature DB >> 12930057

Late onset Alzheimer's disease and apolipoprotein association in the Irish population: relative risk and attributable fraction.

Z Hawi1, K Sheehan, A Lynch, I Evans, N Lowe, B Lawlor, M Gill.   

Abstract

BACKGROUND: Familial and sporadic late onset Alzheimer's disease (LOAD) shows a consistent genetic association with APOE epsilon4. AIMS: To examine the role of APOE in the AD Irish population.
METHODS: One hundred and ten Irish LOAD patients and 217 ethnically-matched controls were genotyped for APOE marker as described by Crook et al. Chi square test was used to compare allelic and genotypic frequencies between patients and controls samples. Attributable fractions were calculated as described by Levin.
RESULTS: A highly significant association between AD and APOE epsilon4 was observed (chi2=37.9, p=0.0000000, RR=2.18). Further, the influence of APOEepsilon4 seems to follow a dose-dependent manner whereby individuals with the genotype APOEepsilon4/4 have a higher relative risk than those heterozygous for the epsilon4 allele (RR=4.03 and 1.76 respectively). The relative risk and the attributable fraction calculated for APOE epsilon4 are consistent with those reported for other European populations. This places the influence of this locus on AD development in the Irish population between those of the Spanish and New York white populations.
CONCLUSION: These findings provide further evidence for the importance of APOE in the development of AD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12930057     DOI: 10.1007/bf02915251

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  20 in total

1.  Association between apolipoprotein E polymorphism and Alzheimer's disease in Koreans.

Authors:  K W Kim; J H Jhoo; K U Lee; D Y Lee; J H Lee; J Y Youn; B J Lee; S H Han; J I Woo
Journal:  Neurosci Lett       Date:  1999-12-31       Impact factor: 3.046

2.  The occurrence of lung cancer in man.

Authors:  M L LEVIN
Journal:  Acta Unio Int Contra Cancrum       Date:  1953

3.  Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale.

Authors:  R S Bucks; D L Ashworth; G K Wilcock; K Siegfried
Journal:  Age Ageing       Date:  1996-03       Impact factor: 10.668

4.  Apolipoprotein E promoter polymorphism and sporadic Alzheimer's disease in a Japanese population.

Authors:  H Toji; H Maruyama; K Sasaki; S Nakamura; H Kawakami
Journal:  Neurosci Lett       Date:  1999-01-04       Impact factor: 3.046

5.  Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid.

Authors:  T Wisniewski; A Golabek; E Matsubara; J Ghiso; B Frangione
Journal:  Biochem Biophys Res Commun       Date:  1993-04-30       Impact factor: 3.575

6.  CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia.

Authors:  M Roth; E Tym; C Q Mountjoy; F A Huppert; H Hendrie; S Verma; R Goddard
Journal:  Br J Psychiatry       Date:  1986-12       Impact factor: 9.319

7.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

8.  Apolipoprotein E4 allele frequency in Spanish Alzheimer and control cases.

Authors:  R Adroer; P Santacruz; R Blesa; S López-Pousa; C Ascaso; R Oliva
Journal:  Neurosci Lett       Date:  1995-04-21       Impact factor: 3.046

9.  Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know.

Authors:  S Seshadri; D A Drachman; C F Lippa
Journal:  Arch Neurol       Date:  1995-11

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  2 in total

1.  Apolipoprotein E promoter polymorphisms (-491A/T and -427T/C) and Alzheimer's disease: no evidence of association in the Irish population.

Authors:  C A Lynch; J Brazil; B Cullen; D Coakley; M Gill; B A Lawlor; Z Hawi
Journal:  Ir J Med Sci       Date:  2007-12-05       Impact factor: 1.568

2.  Impact of genetic variants of apolipoprotein E on lipid profile in patients with Parkinson's disease.

Authors:  Michele L Gregório; Marcela A S Pinhel; Caroline L Sado; Gabriela S Longo; Fábio N Oliveira; Gisele S Amorim; Marcelo A Nakazone; Greiciane M Florim; Camila M Mazeti; Denise P Martins; Waldir A Tognola; Antonio C Brandão; Sidney Pinheiro Júnior; Moacir F de Godoy; Dorotéia R S Souza
Journal:  Biomed Res Int       Date:  2013-09-24       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.